Simon Lloyd
Overview
Explore the profile of Simon Lloyd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou P, de Brito R, Cui Y, Lloyd S, Kunst H, Kutz J, et al.
Eur Arch Otorhinolaryngol
. 2024 Oct;
PMID: 39466369
Purpose: The objective of this consensus is to provide otolaryngologists with appropriate strategies in the management of external auditory canal (EAC) carcinoma. Methods: In the absence of randomized controlled trials,...
2.
Forde C, Smith M, Burghel G, Bowers N, Roberts N, Lavin T, et al.
J Med Genet
. 2024 Jun;
61(9):856-860.
PMID: 38925914
Objectives: New diagnostic criteria for NF2-related schwannomatosis (NF2) were published in 2022. An updated UK prevalence was generated in accordance with these, with an emphasis on the rate of de...
3.
Waqar M, Yaseen O, Chadwick A, Lee J, Khan G, Evans D, et al.
Acta Neurochir (Wien)
. 2024 Apr;
166(1):165.
PMID: 38565732
Purpose: There is no guidance surrounding postoperative venous thromboembolism (VTE) prophylaxis using pharmacological agents (chemoprophylaxis) in patients undergoing skull base surgery. The aim of this study was to compare VTE...
4.
Colombo F, Maye H, Rutherford S, King A, Hammerbeck-Ward C, Whitfield G, et al.
Neurooncol Adv
. 2023 Aug;
5(1):vdad089.
PMID: 37547267
Background: Our neurosurgical unit adopted a model of shared decision-making (SDM) based on multidisciplinary clinics for vestibular schwannoma (VS). A unique feature of this clinic is the interdisciplinary counseling process...
5.
Gregory G, Islim A, Hannan C, Jones A, Hammerbeck-Ward C, Rutherford S, et al.
Neurooncol Adv
. 2023 Jun;
5(Suppl 1):i94-i104.
PMID: 37287576
NF2-schwannomatosis is the most common genetic predisposition syndrome associated with meningioma. Meningioma in NF2-schwannomatosis is a major source of morbidity and mortality. This is due to accumulative tumor burden in...
6.
McClenaghan F, Freeman S, Lloyd S, Stapleton E
Otolaryngol Clin North Am
. 2023 Apr;
56(3):587-598.
PMID: 37019773
Cochlear implantation offers significantly better hearing outcomes than auditory brainstem implantation in patients with vestibular schwannoma. Neither the primary treatment modality nor the cause of the tumor (neurofibromatosis type 2...
7.
Shoakazemi A, Feria A, Kanakis C, Stapleton E, Pathmanaban O, Freeman S, et al.
J Neurol Surg B Skull Base
. 2022 Jul;
83(4):367-373.
PMID: 35903657
The study aimed to determine long-term outcomes in patients with intraoperative electrical conduction block in an anatomically intact facial nerve (FN). Single center retrospective review of prospectively collected database of...
8.
Warner E, Ghedia R, Alatsationos A, Lloyd S, Rea P, Kay Seymour F
J Int Adv Otol
. 2022 Jul;
18(4):347-357.
PMID: 35894532
Background: To assess compliance with guidance produced by the UK body representing all ENT Surgeons (ENT UK) and the British Society of Otology (BSO) on restarting otological surgery after the...
9.
Borsetto D, Sethi M, Clarkson K, Obholzer R, Thomas N, Maratos E, et al.
J Neurosurg
. 2022 Feb;
137(4):1026-1033.
PMID: 35180698
Objective: The growth characteristics of vestibular schwannomas (VSs) under surveillance can be studied using a Bayesian method of growth risk stratification by time after surveillance onset, allowing dynamic evaluations of...
10.
Moualed D, Wong J, Thomas O, Heal C, Saqib R, Choi C, et al.
Eur J Hum Genet
. 2022 Jan;
30(4):458-464.
PMID: 35067678
This study explores the natural history of vestibular, trigeminal and lower cranial nerve schwannomas (VS, TS, LCNS) in patients with Neurofibromatosis type 2 (NF2), to understand how pathogenic variants (PVs)...